KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Teva Pharmaceutical Industries (TEVA) Assets Average (2016 - 2025)

Teva Pharmaceutical Industries' Assets Average history spans 16 years, with the latest figure at $40.3 billion for Q4 2025.

  • For the quarter ending Q4 2025, Assets Average fell 0.59% year-over-year to $40.3 billion, compared with a TTM value of $40.3 billion through Dec 2025, down 0.59%, and an annual FY2025 reading of $40.0 billion, down 3.3% over the prior year.
  • Assets Average for Q4 2025 was $40.3 billion at Teva Pharmaceutical Industries, up from $40.0 billion in the prior quarter.
  • The five-year high for Assets Average was $49.8 billion in Q1 2021, with the low at $38.9 billion in Q1 2025.
  • Average Assets Average over 5 years is $43.8 billion, with a median of $43.2 billion recorded in 2023.
  • Year-over-year, Assets Average fell 11.66% in 2021 and then fell 0.59% in 2025.
  • Tracing TEVA's Assets Average over 5 years: stood at $47.8 billion in 2021, then decreased by 7.59% to $44.1 billion in 2022, then fell by 3.05% to $42.8 billion in 2023, then dropped by 5.25% to $40.5 billion in 2024, then dropped by 0.59% to $40.3 billion in 2025.
  • Per Business Quant, the three most recent readings for TEVA's Assets Average are $40.3 billion (Q4 2025), $40.0 billion (Q3 2025), and $39.3 billion (Q2 2025).